Why We're Passionate
Commitment to Humanity
Atherosclerosis is the leading cause of death in the USA and globally. Statins are a current standard of care, but they only attempt to prevent plaque formation, and the numbers don't lie. One in every five deaths are still cardiac-related, and this fact is unacceptable. Unlike interventions that only delay the inevitable, we're targeting the root cause with our longevity biotechnology approach and aiming to clear existing plaques that have already formed. Our innovative immunotherapy focuses on removing the underlying pathology, allowing your body to recovery naturally.
Groundbreaking Innovation
At Vertical Longevity Pharma, we utilize a platform known as a virus-like particle to specifically target a cell type that contributes to the aging process. Scientific research has established a connection between this cell type and plaque formation, and the clearance of these cells has demonstrated remarkable benefits. Preclinical findings indicate that our senolytic approach can exhibit double the efficacy of the best statins currently available. More importantly, elimination of our target cell has shown the ability to clear established plaques. Our upcoming studies will confirm efficacy in human-relevant primates, potentially showcasing a true cure.
The Power of Targeting Aging
Outside of atherosclerosis, we have observed therapeutic benefits across every organ and system monitored. These include pulmonary protections, hair loss reductions, prolapse prevention, and even lifespan extension. Outside of these, the scientific literature give us strong reason to believe that we can impact chronic kidney disease, vascular dementia, and metabolic disorder, to name but a few. This is the power of targeting a fundamental driver of human aging. A single senolytic therapy than can positively impact the entire organism.
Longevity for All Who Desire It
Financial projections position this senolytic vaccine as cost-competitive with statins, while also offering multi-morbidity intervention capabilities. As we scale, we anticipate further cost reductions for the consumer. Our longevity biotech platform can be manufactured in a thermostable manner, facilitating global expansion into even the most remote areas of the Earth. We are on a mission to provide everyone with a choice in longevity intervention, regardless of socioeconomic status or geopolitical position.
Contact Us
